These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34656436)

  • 21. Efficacy of random-start controlled ovarian stimulation in cancer patients.
    Kim JH; Kim SK; Lee HJ; Lee JR; Jee BC; Suh CS; Kim SH
    J Korean Med Sci; 2015 Mar; 30(3):290-5. PubMed ID: 25729252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial.
    Letourneau J; Juarez-Hernandez F; Wald K; Ribeiro S; Wang A; McCulloch CE; Mok-Lin E; Dolezal M; Chien AJ; Cedars MI; Rosen M
    J Assist Reprod Genet; 2021 Sep; 38(9):2455-2463. PubMed ID: 34312774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
    Cakmak H; Katz A; Cedars MI; Rosen MP
    Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature.
    Keskin U; Ercan CM; Yilmaz A; Babacan A; Korkmaz C; Duru NK; Ergun A
    J Pak Med Assoc; 2014 Jul; 64(7):830-2. PubMed ID: 25255597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women.
    Checa Vizcaíno MA; Corchado AR; Cuadri ME; Comadran MG; Brassesco M; Carreras R
    Reprod Biomed Online; 2012 Jun; 24(6):606-10. PubMed ID: 22503276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of letrozole added to gonadotropins in controlled ovarian stimulation protocols on the yield and maturity of retrieved oocytes.
    Ben-Haroush A; Wertheimer A; Klochendler E; Sapir O; Shufaro Y; Oron G
    Gynecol Endocrinol; 2019 Apr; 35(4):324-327. PubMed ID: 30596311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
    Muteshi C; Child T; Ohuma E; Fatum M
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.
    Oktay K; Buyuk E; Libertella N; Akar M; Rosenwaks Z
    J Clin Oncol; 2005 Jul; 23(19):4347-53. PubMed ID: 15824416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.
    Cavagna F; Pontes A; Cavagna M; Dzik A; Donadio NF; Portela R; Nagai MT; Gebrim LH
    Curr Oncol; 2018 Dec; 25(6):e527-e532. PubMed ID: 30607119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation.
    Huang H; Itaya Y; Samejima K; Ichinose S; Narita T; Matsunaga S; Saitoh M; Takai Y
    J Ovarian Res; 2022 Jan; 15(1):2. PubMed ID: 34983605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients.
    Suzuki R; Horage-Okutsu Y; Kawahara T; Nakamura K; Shiraishi E; Iwahata H; Suzuki-Takahashi Y; Sugishita Y; Takae S; Suzuki N
    J Obstet Gynaecol Res; 2023 Mar; 49(3):973-979. PubMed ID: 36606606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fertility preservation in women with breast cancer.
    Rodriguez-Wallberg KA; Oktay K
    Clin Obstet Gynecol; 2010 Dec; 53(4):753-62. PubMed ID: 21048442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of controlled ovarian stimulation with tamoxifen for patients with estrogen-sensitive breast cancer: A systematic review and meta-analysis.
    Yoshida T; Takahashi O; Suzuki Y; Ota E; Hirata T
    Reprod Med Biol; 2023; 22(1):e12543. PubMed ID: 37745035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation.
    İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M
    Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
    Alvarez RM; Ramanathan P
    Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian stimulation and oocyte cryopreservation in females with cancer.
    Oktay KH; Turan V
    Curr Opin Oncol; 2023 Sep; 35(5):412-419. PubMed ID: 37498110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.
    Oktay K; Turan V; Bedoschi G; Pacheco FS; Moy F
    J Clin Oncol; 2015 Aug; 33(22):2424-9. PubMed ID: 26101247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective case series of women with estrogen receptor-positive breast cancer: levels of tamoxifen metabolites in controlled ovarian stimulation with high-dose tamoxifen.
    Balkenende EM; Dahhan T; Linn SC; Jager NG; Beijnen JH; Goddijn M
    Hum Reprod; 2013 Apr; 28(4):953-9. PubMed ID: 23335608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.